Cubist Pharmaceuticals (United States)
Cubist Pharmaceuticals, Inc. was an American biopharmaceutical company that targeted pathogens like MRSA. . The company employed 638 people, mostly in Lexington, Massachusetts. On 8 December 2014, Merck & Co. acquired Cubist for $102 per share in cash. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Cubist Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
39%
Total
Publications
576
Total Open
Publications
224
Total
Citations
38K
Open Access
Percentage
39%
Total
Publications
576
Total Open
Publications
224
Total
Citations
38K
Breakdown
Publisher Open
15%
Both
16%
Other Platform Open
8%
Closed
61%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 34%
62
Hybrid 9%
17
No Guarantees 57%
103
Other Platform Open
Other Internet 51%
71
Domain 46%
65
Institution 13%
18
Public 2%
3
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
DOI | Other Internet | 70 |
PubMed Central | Domain | 65 |
University of Michigan–Ann Arbor | Institution | 4 |
University of Melbourne | Institution | 4 |
Figshare | Public | 3 |
Washington University in St. Louis | Institution | 2 |
University of Waterloo | Institution | 2 |
Europe PMC | Domain | 2 |
Unknown Repository | Other Internet | 1 |
University of Pisa | Institution | 1 |